Dr. Anja Trillhaase from the ICG will give an invited talk at the Conference on Advancements in Organoid Sciences

The aim of this meeting, organized by Prof. Dr. med. Sven Hendrix from Medical School Hamburg (MSH), is to create a platform for leaders in organoid research to discuss the advancements in 3D culture systems.

Date: 26th – 27th January 2023
Location: “GOLDEN EGG” at MSH, Hamburg

Dr. Anja Trillhaase from the ICG will present her work on using organoids to study angiogenesis.


Online-Ringvorlesung: Geschlechtersensible Medizin

Online-Ringvorlesung Oktober 2021 bis Februar 2022

Geschlechtersensible Medizin

immer donnerstags von 18:00 bis 19:30 Uhr online über Zoom: https://bit.ly/ws21-22-rv-gendersensible_medizin

Kenncode: 845532

Prof. Dr. med. Sabine Oertelt-Prigione
Medizinische Fakultät der Universität Bielefeld, Radboud University Nijmegen
Geschlechtersensible Medizin 2021: ein Überblick

Prof.in Dr. med. Dr. rer. nat. Bettina Pfleiderer
Medizinische Fakultät der Universität Münster
Weibliche Depression, männliche Depression – gleiche Diagnose und doch ganz anders!

Prof. Dr. Clara Lehmann
Innere Medizin der Uniklinik Köln
Hat das Immunsystem ein Geschlecht?

Prof. Dr. rer. nat. Jeanette Erdmann
Institut für Kardiogenetik, UKSH Campus Lübeck
Frauen in der (Medizinischen) Forschung

Prof. Dr. med. Anne Letsch
Onkologisches Zentrum, UKSH Campus Kiel
Spezifische Gender-Aspekte bei Nebenwirkungen von Krebstherapien

PD Dr. med. Doreen Richardt
Klinik für Herzchirurgie und Chirurgie, UKSH Campus Lübeck
Frauenherzen und andere Mysterien

Dr. med. Ute Seeland
Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie, Charité Berlin
Einfluss von Östrogenen und kardiovaskulären Risikofaktoren auf die arterielle Gefäßsteifigkeit

Prof. Dr. med. Axel S. Merseburger
Klinik für Urologie, UKSH Campus Lübeck
Geschlechtsspezifische Unterschiede bei urologischen Krebserkrankungen

Prof. Dr. rer. nat. Jeanette Erdmann
Institut für Kardiogenetik, UKSH Campus Lübeck
Dr. rer. nat. Christine Friedrich
Klinik für Herz- und Gefäßchirurgie, UKSH Campus Kiel
Gendermedizin in der Herzforschung –wichtig für Frauen und Männer

Jeanette Erdmann is a new member of the National Academy of Sciences Leopoldina

The National Academy of Sciences Leopoldina unites researchers with special expertise in their respective fields. The criterion for admission is outstanding scientific achievement.

Among scientists, admission to the ranks of Leopoldina members is considered one of the highest honours – Prof. Jeanette Erdmann has received it. The biologist is the only professor at the University of Lübeck who is currently a member of the National Academy of Sciences Leopoldina.

Her path into the world of research led Jeanette Erdmann to the Institute of Human Genetics in Bonn after completing her studies at the University of Cologne, where she wrote her doctoral thesis. After her doctorate, she worked as a research group leader in Berlin and Regensburg. Jeanette Erdmann completed her habilitation at the University of Regensburg. She has worked at the University of Lübeck since 2003.

In 2012 she was appointed W3 Professor for Life in Lübeck and subsequently DZHK Professor by the German Centre for Cardiovascular Research. Since 2013, she has successfully led the newly founded Institute of Cardiogenetics, which aims to better understand the genetic factors that lead to cardiovascular diseases, e.g. atherosclerosis and heart attacks, in order to develop new therapies. “Since the beginning of my PhD, I have been working on the inheritance of common, so-called complex diseases, first with schizophrenia and depression and for 15 years now with cardiovascular diseases. For a few years now, however, I have expanded my field of research and we are currently also developing a therapy for a rare neuromuscular disease that I diagnosed myself with a few years ago,” reports Prof. Jeanette Erdmann.

With her expertise, the director of the Institute of Cardiogenetics at the University of Lübeck now strengthens the Leopoldina, which is a classic learned society with its approximately 1,600 members from almost all scientific fields. The proportion of female scientists among its members has risen from seven to 15 per cent in the past ten years. “Being accepted into the Leopoldina is a success and a great honour for me in two ways,” explains Prof. Erdmann. “On the one hand, I am pleased that my scientific work has been recognised by the Academy. Here I would like to thank my staff in particular, as well as the national and international cooperation partners of the past 15 years, without whom this success would not have been possible. On the other hand, admission to the Leopoldina rewards the efforts of the past years and perhaps strengthens more young women and people with physical limitations to embark on the fulfilling, but sometimes also rocky path of an academic career. I would be extremely pleased about that.”

The Academy’s tasks include representing German science abroad and advising politicians and the public. The Leopoldina unites researchers with special expertise in their respective fields. The approximately 1,600 Academy members come from over 30 countries. Every year, about 50 scientists are elected to the Academy for life in a multi-stage selection process. Admission follows a nomination by Academy members, which is followed by a multi-stage selection process by the Section, the Class and the Presidium.

Since the Academy was founded in 1652, more than 7,000 personalities have been admitted to its ranks. These have included Marie Curie, Charles Darwin, Albert Einstein, Johann Wolfgang von Goethe, Alexander von Humboldt, Justus von Liebig and Max Planck.

Gene Sequencing Identifies Perturbation in Nitric Oxide Signaling as a Nonlipid Molecular Subtype of Coronary Artery Disease.

Khera AV, Wang M, Chaffin M, Emdin CA, Samani NJ, Schunkert H, Watkins H, McPherson R, Erdmann J, Elosua R, Boerwinkle E, Ardissino D, Butterworth AS, Di Angelantonio E, Naheed A, Danesh J, Chowdhury R, Krumholz HM, Sheu WH, Rich SS, Rotter JI, Chen YI, Gabriel S, Lander ES, Saleheen D, Kathiresan S.

Circ Genom Precis Med. 2022 Dec;15(6):e003598. doi: 10.1161/CIRCGEN.121.003598. Epub 2022 Oct 10.


First “Stem Cell Club Lübeck” on March 7, 2023 at 3:00pm

The Stem Cell Club Lübeck (SCCL) is a series of virtual research talks, hosted by Dr. Anja Trillhaase from the Institute for Cardiogenetics.

The SCCL aims to connect stem cell and organoid researchers across Germany, and in the northern areas in particular.

Especially, junior researchers are invited to join the meetings and connect with peers.

Every two months a virtual meeting will be held, where one invited external speaker and one internal speaker from Lübeck, Hamburg or Kiel will present and discuss their work with the audience.

This will be a great opportunity to further bring together research teams working on stem cells and organoids, to intensify the collaborative work and to give junior researchers the possibility to get in touch with different researchers in the field apart from big conferences.

The first Stem Cell Club Lübeck meeting will take place on March 7th 2023 at 3 pm!
Add to your calendar

In vitro models for the neurovascular unit generated from iPSCs for analysis of aging and Alzheimer disease.

Dr. rer. nat. Matthias Jung, Martin-Luther-Universität Halle-Wittenberg, Germany

iPSC-derived blood vessel organoids as angiogenesis model.

Dr. rer. nat. Anja Trillhaase, Institute for Cardiogenetics, University of Lübeck, Germany

Registration: https://zoom.us/meeting/register/tJAtdOGtrT4jEtBanjjmR5Adxci2EQXttOS2

Franziska Haarich from ICG will give an invited talk at the Festival of Genomics & Biodata

The Festival of Genomics & Biodata is the world’s largest genomics and biodata event and it is THE place for the global genomics community to meet, learn and get inspired. You can build meaningful relationships with 7,000+ attendees from across the globe, enjoy the many festival activities and hear incredible talks from around 200 speakers.

Date: 25th – 26th January 2023
Location: Business Design Centre

One invited speaker is Franziska Haarich from the ICG. She will speak about CRISPRoff as potential treatment strategy for Collagen-VI Congenital Muscular Dystrophy.


Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants.

Krishna G. Aragam, Tao Jiang, Anuj Goel, Stavroula Kanoni, Brooke N. Wolford, Deepak S. Atri, Elle M. Weeks, Minxian Wang, George Hindy, Wei Zhou, Christopher Grace, Carolina Roselli, Nicholas A. Marston, Frederick K. Kamanu, Ida Surakka, Loreto Muñoz Venegas, Paul Sherliker, Satoshi Koyama, Kazuyoshi Ishigaki, Bjørn O. Åsvold, Michael R. Brown, Ben Brumpton, Paul S. de Vries, Olga Giannakopoulou, Panagiota Giardoglou, Daniel F. Gudbjartsson, Ulrich Güldener, Syed M. Ijlal Haider, Anna Helgadottir, Maysson Ibrahim, Adnan Kastrati, Thorsten Kessler, Theodosios Kyriakou, Tomasz Konopka, Ling Li, Lijiang Ma, Thomas Meitinger, Sören Mucha, Matthias Munz, Federico Murgia, Jonas B. Nielsen, Markus M. Nöthen, Shichao Pang, Tobias Reinberger, Gavin Schnitzler, Damian Smedley, Gudmar Thorleifsson, Moritz von Scheidt, Jacob C. Ulirsch, Biobank Japan, EPIC-CVD, David O. Arnar, Noël P. Burtt, Maria C. Costanzo, Jason Flannick, Kaoru Ito, Dong-Keun Jang, Yoichiro Kamatani, Amit V. Khera, Issei Komuro, Iftikhar J. Kullo, Luca A. Lotta, Christopher P. Nelson, Robert Roberts, Gudmundur Thorgeirsson, Unnur Thorsteinsdottir, Thomas R. Webb, Aris Baras, Johan L. M. Björkegren, Eric Boerwinkle, George Dedoussis, Hilma Holm, Kristian Hveem, Olle Melander, Alanna C. Morrison, Marju Orho-Melander, Loukianos S. Rallidis, Arno Ruusalepp, Marc S. Sabatine, Kari Stefansson, Pierre Zalloua, Patrick T. Ellinor, Martin Farrall, John Danesh, Christian T. Ruff, Hilary K. Finucane, Jemma C. Hopewell, Robert Clarke, Rajat M. Gupta, Jeanette Erdmann, Nilesh J. Samani, Heribert Schunkert, Hugh Watkins, Cristen J. Willer, Panos Deloukas, Sekar Kathiresan, Adam S. Butterworth & The CARDIoGRAMplusCD Consortium

Nature Genet. 2022 December 6. https://doi.org/10.1038/s41588-022-01233-6


NGS-driven molecular diagnosis of heterogeneous hereditary neurological disorders reveals novel and known variants in disease-causing genes.

Khan A, Tian S, Tariq M, Khan S, Safeer M, Ullah N, Akbar N, Javed I, Asif M, Ahmad I, Ullah S, Satti HS, Khan R, Naeem M, Ali M, Rendu J, Fauré J, Dieterich K, Latypova X, Baig SM, Malik NA, Zhang F, Khan TN, Liu C.

Mol Genet Genomics. 2022 Aug 24. doi: 10.1007/s00438-022-01945-8.


A new MD in town – unfortunately not in Lübeck

On June 24, 2022 Svenja Vishnolia has very successfully defended her MD thesis “Allele-specific RNA-targeted therapy as a treatment strategy for Col6-CMD”. Svenja is the first to complete her doctoral thesis on Collagen-6. She did a fantastic job. 
It was a wonderful talk and an impressive Q&A session. Congratulations!

Scroll to Top